Evidence map›Paper›PMID 33165530›Full record

ArticleThe Journal of clinical endocrinology and metabolism2021

Diabetes, Brain Infarcts, Cognition, and Small Vessels in the Canadian Alliance for Healthy Hearts and Minds Study.

Hertzel C Gerstein, Eric E Smith, Chinthanie Ramasundarahettige, Dipika Desai, Philip Awadalla, Philippe Broet, Sandra Black, Trevor J B Dummer, Jason Hicks, Alan Moody and 7 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Cohort Profile: The Ontario Health Study (OHS).International journal of epidemiology · 2023
    Article
  10. Article
  11. Diabetes and dementia: Clinical perspective, innovation, knowledge gaps.Journal of diabetes and its complications · 2022
    Review
  12. Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 1 country.

Hertzel C GersteinPopulation Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Eric E SmithHotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Chinthanie RamasundarahettigePopulation Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Dipika DesaiPopulation Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Philip AwadallaDepartment of Molecular Genetics, Ontario Institute for Cancer Research, University of Toronto, Toronto, Ontario, Canada.
Philippe BroetDepartment of Preventive and Social Medicine, École de santé publique, Université de Montréal, Montreal, Quebec, Canada.
Sandra BlackDepartment of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Trevor J B DummerCancer Control Research, BC Cancer, and the School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Jason HicksAtlantic PATH, Dalhousie University, Halifax, Nova Scotia, Canada.
Alan MoodyDepartment of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Jean-Claude TardifDepartment of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Koon K TeoPopulation Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Jennifer VenaAlberta's Tomorrow Project, Cancer Research and Analytics, Cancer Control Alberta, Alberta Health Services, Edmonton, Alberta, Canada.
Salim YusufPopulation Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Douglas S LeeInstitute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Matthias G FriedrichDepartment of Medicine and Diagnostic Radiology, McGill University, Montreal, Quebec, Canada.
Sonia S AnandPopulation Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Population Health Research Institute · CASunnybrook Health Science Centre · CAAlberta Health Services · CACentre Hospitalier Universitaire Sainte-Justine · CADalhousie University · CAMcGill University · CAMontreal Heart Institute · CAOntario Institute for Cancer Research · CAUniversity Health Network · CAUniversity of British Columbia · CAUniversity of Calgary · CA

Funding

CIHR FDN-143255CIHR FDN-143313CIHR FDN 154317
6 · The paper itself

Abstract

backgroundDiabetes is a risk factor for cerebrovascular disease and cognitive impairment. The anatomical basis for this is uncertain.

methodsThe Canadian Alliance for Healthy Hearts and Minds collected brain and carotid magnetic resonance imaging (MRI) and 2 cognitive tests (the Digit Symbol Substitution Test and the Montreal Cognitive Assessment test) in a cross-sectional sample of men and women. Brain MRIs identified brain infarcts (BI), lacunar BI, high white matter hyperintensity (WMH), vascular brain injury (VBI; BI or high WMH), and small vessel VBI (lacunar BI or high WMH). Carotid MRIs estimated carotid wall volume, a measure of subclinical atherosclerosis. Cognitive scores were standardized to each site's mean score, and cognitive impairment was identified by 1 or both test scores ≤1 standard deviation below the site's mean score on that test.

resultsThe 7733 participants included 495 participants (6.4%) with diabetes, of whom 388 were taking diabetes drugs. After age and sex adjustment, diabetes was independently associated with BI (odds ratio [OR] 1.53, 95% confidence interval [CI] 1.05, 2.24), VBI (OR 1.64, 95% CI 1.26, 2.13), small vessel VBI (OR 1.67, 95% CI 1.28, 2.19), and cognitive impairment (OR 1.47, 95% CI 1.20, 1.80). The association between diabetes and small vessel VBI persisted after adjustment for cerebrovascular disease risk factors and nonlacunar infarcts (OR 1.52, 95% CI 1.15, 2.01), and the association with cognitive impairment persisted after adjustment for small vessel VBI (OR 1.27, 95% CI 1.03, 1.56).

conclusionSmall vessel disease characterizes much of the relationship between diabetes and VBI. However, additional factors are required to disentangle the relationship between diabetes and cognitive impairment.

Indexed as

AdultAgedBrainBrain InfarctionCanadaCerebrovascular DisordersCognitive DysfunctionCross-Sectional StudiesDiabetes MellitusFemaleHumansMagnetic Resonance ImagingMaleMicrocirculationMiddle AgedNeuroimagingcognitiondiabetesmicrovascularstroke

Identifiers

PMID33165530
PMCPMC7823245
OpenAlexW3101656795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.